Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

John Gerber

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Living Beings

Dogs
HIV-1

Chemicals & Drugs

Physiology

Procedures

Combination Drug Therapy

Anatomy

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
11
Acosta, Edward
8
Fichtenbaum, Carl
7
Aberg, Judith
6
Eron, Joseph
6
Kuritzkes, Daniel
5
Gal, Joseph
4
Currier, Judith
4
Gulick, Roy
4
Rosenkranz, Susan
4
Segal, Yoninah
4
Zahniser, Nancy
3
Zolopa, Andrew
3
Smeaton, Laura
3
Murphy, Robert
3
Alston, Beverly

Sign-in to see all Coauthors

Publications

TOP 3
Haas David W; Koletar Susan L; Laughlin Laura; Kendall Michelle A; Suckow Carol; Gerber John G; Zolopa Andrew R; Bertz Richard; Child Michael J; Hosey Lara; Alston-Smith Beverly; Acosta Edward P;
Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir.
Kiser Jennifer J; Gerber John G; Predhomme Julie A; Wolfe Pamela; Flynn Devon M; Hoody Dorie W
Drug/Drug interaction between lopinavir/ritonavir and rosuvastatin in healthy volunteers.
Gerber John G; Kitch Douglas W; Fichtenbaum Carl J; Zackin Robert A; Charles Stéphannie; Hogg Evelyn; Acosta Edward P; Connick Elizabeth; Wohl David; Kojic E Milu; Benson Constance A; Aberg Judith A
Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of John Gerber (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Haas David W; Koletar Susan L; Laughlin Laura; Kendall Michelle A; Suckow Carol; Gerber John G; Zolopa Andrew R; Bertz Richard; Child Michael J; Hosey Lara; Alston-Smith Beverly; Acosta Edward P;
Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir.
Journal of acquired immune deficiency syndromes (1999) 2009;50(3):290-3.
2008: Kiser Jennifer J; Gerber John G; Predhomme Julie A; Wolfe Pamela; Flynn Devon M; Hoody Dorie W
Drug/Drug interaction between lopinavir/ritonavir and rosuvastatin in healthy volunteers.
Journal of acquired immune deficiency syndromes (1999) 2008;47(5):570-8.
2008: Gerber John G; Kitch Douglas W; Fichtenbaum Carl J; Zackin Robert A; Charles Stéphannie; Hogg Evelyn; Acosta Edward P; Connick Elizabeth; Wohl David; Kojic E Milu; Benson Constance A; Aberg Judith A
Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186.
Journal of acquired immune deficiency syndromes (1999) 2008;47(4):459-66.
2007: Acosta Edward P; Kendall Michelle A; Gerber John G; Alston-Smith Beverly; Koletar Susan L; Zolopa Andrew R; Agarwala Sangeeta; Child Michael; Bertz Richard; Hosey Lara; Haas David W
Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.
Antimicrobial agents and chemotherapy 2007;51(9):3104-10.
2006: Wu Hulin; Huang Yangxin; Acosta Edward P; Park Jeong-Gun; Yu Song; Rosenkranz Susan L; Kuritzkes Daniel R; Eron Joseph J; Perelson Alan S; Gerber John G
Pharmacodynamics of antiretroviral agents in HIV-1 infected patients: using viral dynamic models that incorporate drug susceptibility and adherence.
Journal of pharmacokinetics and pharmacodynamics 2006;33(4):399-419.
2006: Aberg Judith A; Rosenkranz Susan L; Fichtenbaum Carl J; Alston Beverly L; Brobst Susan W; Segal Yoninah; Gerber John G;
Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108.
AIDS (London, England) 2006;20(5):725-9.
2006: Gripshover Barbara M; Ribaudo Heather; Santana Jorge; Gerber John G; Campbell Thomas B; Hogg Evelyn; Jarocki Bernadette; Hammer Scott M; Kuritzkes Daniel R;
Amdoxovir versus placebo with enfuvirtide plus optimized background therapy for HIV-1-infected subjects failing current therapy (AACTG A5118).
Antiviral therapy 2006;11(5):619-23.
2005: Glesby Marshall J; Aberg Judith A; Kendall Michelle A; Fichtenbaum Carl J; Hafner Richard; Hall Stephen; Grosskopf Nicole; Zolopa Andrew R; Gerber John G;
Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers.
Clinical pharmacology and therapeutics 2005;78(2):143-53.
2005: Gerber John G; Rosenkranz Susan L; Fichtenbaum Carl J; Vega Jose M; Yang Amy; Alston Beverly L; Brobst Susan W; Segal Yoninah; Aberg Judith A;
Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study.
Journal of acquired immune deficiency syndromes (1999) 2005;39(3):307-12.
2005: Wu Hulin; Huang Yangxin; Acosta Edward P; Rosenkranz Susan L; Kuritzkes Daniel R; Eron Joseph J; Perelson Alan S; Gerber John G
Modeling long-term HIV dynamics and antiretroviral response: effects of drug potency, pharmacokinetics, adherence, and drug resistance.
Journal of acquired immune deficiency syndromes (1999) 2005;39(3):272-83.
2005: King Jennifer R; Gerber John G; Fletcher Courtney V; Bushman Lane; Acosta Edward P
Indinavir protein-free concentrations when used in indinavir/ritonavir combination therapy.
AIDS (London, England) 2005;19(10):1059-63.
2005: Kiser Jennifer J; Anderson Peter L; Gerber John G
Therapeutic drug monitoring: pharmacologic considerations for antiretroviral drugs.
Current HIV/AIDS reports 2005;2(2):61-7.
2005: Wyles David L; Gerber John G
Abacavir pharmacokinetics in hepatic dysfunction.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(6):909-10.
2005: Wyles David L; Gerber John G
Antiretroviral drug pharmacokinetics in hepatitis with hepatic dysfunction.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(1):174-81.
2005: Dunmire David; Freedman Teresa B; Nafie Laurence A; Aeschlimann Christine; Gerber John G; Gal Joseph
Determination of the absolute configuration and solution conformation of the antifungal agents ketoconazole, itraconazole, and miconazole with vibrational circular dichroism.
Chirality 2005;17 Suppl():S101-8.
2004: Acosta Edward P; Wu Hulin; Hammer Scott M; Yu Song; Kuritzkes Daniel R; Walawander Ann; Eron Joseph J; Fichtenbaum Carl J; Pettinelli Carla; Neath Denise; Ferguson Elaine; Saah Alfred J; Gerber John G;
Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individuals.
Journal of acquired immune deficiency syndromes (1999) 2004;37(3):1358-66.
2004: Dilmaghanian Shahrzad; Gerber John G; Filler Scott G; Sanchez Angela; Gal Joseph
Enantioselectivity of inhibition of cytochrome P450 3A4 (CYP3A4) by ketoconazole: Testosterone and methadone as substrates.
Chirality 2004;16(2):79-85.
2004: Gerber John G; Rhodes Robert J; Gal Joseph
Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19.
Chirality 2004;16(1):36-44.
2003: Dubé Michael P; Stein James H; Aberg Judith A; Fichtenbaum Carl J; Gerber John G; Tashima Karen T; Henry W Keith; Currier Judith S; Sprecher Dennis; Glesby Marshall J;
Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(5):613-27.
2003: Glesby Marshall J; Gerber John G
Editorial comment: drug-drug interactions, hepatitis C, and mitochondrial toxicity.
The AIDS reader 2003;13(7):346-7.
2003: Gerber John G; Acosta Edward P
Therapeutic drug monitoring in the treatment of HIV-infection.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2003;27(2):117-28.
2002: Schambelan Morris; Benson Constance A; Carr Andrew; Currier Judith S; Dubé Michael P; Gerber John G; Grinspoon Steven K; Grunfeld Carl; Kotler Donald P; Mulligan Kathleen; Powderly William G; Saag Michael S;
Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.
Journal of acquired immune deficiency syndromes (1999) 2002;31(3):257-75.
2002: Acosta Edward P; Gerber John G;
Position paper on therapeutic drug monitoring of antiretroviral agents.
AIDS research and human retroviruses 2002;18(12):825-34.
2002: Pereira Arlene S; Smeaton Laura M; Gerber John G; Acosta Edward P; Snyder Sally; Fiscus Susan A; Tidwell Richard R; Gulick Roy M; Murphy Robert L; Eron Joseph J
The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (AIDS clinical trials group study 850).
The Journal of infectious diseases 2002;186(2):198-204.
2002: Fichtenbaum Carl J; Gerber John G; Rosenkranz Susan L; Segal Yoninah; Aberg Judith A; Blaschke Terrence; Alston Beverly; Fang Fang; Kosel Bradley; Aweeka Francesca;
Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047.
AIDS (London, England) 2002;16(4):569-77.
2002: Fichtenbaum Carl J; Gerber John G
Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection.
Clinical pharmacokinetics 2002;41(14):1195-211.
2001: Becker S; Fisher A; Flexner C; Gerber J G; Haubrich R; Kashuba A D; Luber A D; Piscitelli S C
Pharmacokinetic parameters of protease inhibitors and the Cmin/IC50 ratio: call for consensus.
Journal of acquired immune deficiency syndromes (1999) 2001;27(2):210-1.
2001: Gerber J G; Rosenkranz S; Segal Y; Aberg J; D'Amico R; Mildvan D; Gulick R; Hughes V; Flexner C; Aweeka F; Hsu A; Gal J;
Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: results of AIDS Clinical Trials Group (ACTG) 401.
Journal of acquired immune deficiency syndromes (1999) 2001;27(2):153-60.
2001: Grodesky M; Acosta E P; Fujita N; Mason S; Gerber J G
Combination therapy with indinavir, ritonavir, and delavirdine and nucleoside reverse transcriptase inhibitors in patients with HIV/AIDS who have failed multiple antiretroviral combinations.
HIV clinical trials 2001;2(3):193-9.
2001: Gulick R M; Smeaton L M; D'Aquila R T; Eron J J; Currier J S; Gerber J G; Acosta E; Sommadossi J P; Tung R; Snyder S; Kuritzkes D R; Murphy R L;
Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373.
The Journal of infectious diseases 2001;183(5):715-21.
2000: Gerber J G
Using pharmacokinetics to optimize antiretroviral drug-drug interactions in the treatment of human immunodeficiency virus infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30 Suppl 2():S123-9.
2000: Johnson S C; Gerber J G
Advances in HIV/AIDS therapy.
Advances in internal medicine 2000;45():1-40.
1999: Zhang X Q; Schooley R T; Gerber J G
The effect of increasing alpha1-acid glycoprotein concentration on the antiviral efficacy of human immunodeficiency virus protease inhibitors.
The Journal of infectious diseases 1999;180(6):1833-7.
1999: Murphy R L; Gulick R M; DeGruttola V; D'Aquila R T; Eron J J; Sommadossi J P; Currier J S; Smeaton L; Frank I; Caliendo A M; Gerber J G; Tung R; Kuritzkes D R
Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study Team.
The Journal of infectious diseases 1999;179(4):808-16.
1999: Gerber J G; Detmar-Hanna D; Zahniser N R
Lack of an effect of age on beta-adrenoceptor-mediated lipolysis in isolated human adipocytes.
The journals of gerontology. Series A, Biological sciences and medical sciences 1999;54(2):B71-7.
1998: Gass R J; Gal J; Fogle P W; Detmar-Hanna D; Gerber J G
Neither dapsone hydroxylation nor cortisol 6beta-hydroxylation detects the inhibition of CYP3A4 by HIV-1 protease inhibitors.
European journal of clinical pharmacology 1998;54(9-10):741-7.
1998: Davy K P; Tanaka H; Andros E A; Gerber J G; Seals D R
Influence of age on arterial baroreflex inhibition of sympathetic nerve activity in healthy adult humans.
The American journal of physiology 1998;275(5 Pt 2):H1768-72.
1998: Andros E A; Gerber J G
The effect of adenosine on the reduced heart rate response to exercise in the elderly.
The journals of gerontology. Series A, Biological sciences and medical sciences 1998;53(2):M87-91.
1997: Payne N A; Gerber J G
Effect of adenosine and histamine receptor stimulation on canine histamine release to pentagastrin.
Digestion 1997;58(4):352-60.
1996: Gerber J G; Payne N A
Secretin inhibits canine gastric acid secretion in response to pentagastrin by modulating gastric histamine release.
The Journal of pharmacology and experimental therapeutics 1996;279(2):718-23.
1996: Payne N A; Gerber J G
The effect of beta andrenoceptor stimulation of canine stomach on pentagastrin-stimulated histamine release.
The Journal of pharmacology and experimental therapeutics 1996;276(3):984-8.
1996: Andros E; Detmar-Hanna D; Suteparuk S; Gal J; Gerber J G
The effect of aging on the pharmacokinetics and pharmacodynamics of prazosin.
European journal of clinical pharmacology 1996;50(1-2):41-6.
1995: Gerber J G; Payne N A
The role of gastric histamine release in the acid secretory response to pentagastrin and methacholine in the dog.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 1995;44(8):327-34.
1995: Suteparuk S; Nies A S; Andros E; Gerber J G
The role of adenosine in promoting cardiac beta-adrenergic subsensitivity in aging humans.
The journals of gerontology. Series A, Biological sciences and medical sciences 1995;50(3):B128-34.
1993: Gerber J G; Franca G; Byyny R L; LoVerde M; Nies A S
The hypotensive action of captopril and enalapril is not prostacyclin dependent.
Clinical pharmacology and therapeutics 1993;54(5):523-32.
1992: Nies A S; Andros E A; Gerber J G
Platelet alpha 2-adrenergic receptor responsiveness is increased in elderly men but not in elderly women.
Clinical pharmacology and therapeutics 1992;52(6):605-8.
1992: Payne N A; Gerber J G
Differential effects of somatostatin and prostaglandins on gastric histamine release to pentagastrin.
The Journal of pharmacology and experimental therapeutics 1992;263(2):520-6.
1992: Gilmore D A; Gal J; Gerber J G; Nies A S
Age and gender influence the stereoselective pharmacokinetics of propranolol.
The Journal of pharmacology and experimental therapeutics 1992;261(3):1181-6.
1992: Zahniser N R; Wiser A; Cass W A; Curella P; Gerber J G; Nies A S
Terbutaline-induced desensitization of polymorphonuclear leukocyte beta 2-adrenergic receptors in young and elderly subjects.
Clinical pharmacology and therapeutics 1992;51(4):432-9.
1992: Gerber J G; Payne N A
The role of gastric secretagogues in regulating gastric histamine release in vivo.
Gastroenterology 1992;102(2):403-8.
1991: Nies A S; Beckmann M L; Gerber J G
Contrasting effects of changes in salt balance on the renovascular response to A1-adenosine receptor stimulation in vivo and in vitro in the rat.
The Journal of pharmacology and experimental therapeutics 1991;256(2):542-6.
1990: Gerber J G; LoVerde M; Byyny R L; Nies A S
The antihypertensive efficacy of hydrochlorothiazide is not prostacyclin dependent.
Clinical pharmacology and therapeutics 1990;48(4):424-30.
1990: Klein C; Gerber J G; Payne N A; Nies A S
The effect of age on the sensitivity of the alpha 1-adrenoceptor to phenylephrine and prazosin.
Clinical pharmacology and therapeutics 1990;47(4):535-9.
1990: Gerber J G; Beckmann M L; Loverde M; Byyny R L; Nies A S
Hydralazine does not stimulate prostacyclin biosynthesis in hypertensive patients.
The American journal of the medical sciences 1990;299(3):170-4.
1990: Klein C E; Gerber J G; Nies A S
Lack of an effect of age on the response to clonidine.
Clinical pharmacology and therapeutics 1990;47(1):61-7.
1990: Payne N A; Gerber J G
Parietal cell preparation and arachidonate metabolism.
Methods in enzymology 1990;187():505-13.
1989: Gerber J G; Bedell K S; Nies A S
Atrial natriuretic peptide blocks the renal vasoconstrictor response to hypertonic saline in the dog.
The Journal of pharmacology and experimental therapeutics 1989;251(1):77-81.
1989: Payne N A; Zirrolli J A; Gerber J G
Analysis of histamine and N tau-methylhistamine in plasma by gas chromatography-negative ion-chemical ionization mass spectrometry.
Analytical biochemistry 1989;178(2):414-20.
1989: Zahniser N R; Bier-Laning C M; Gerber J G; Nies A S
Timolol-induced up-regulation of polymorphonuclear leukocyte beta 2-adrenergic receptors in the elderly.
Clinical pharmacology and therapeutics 1989;45(5):469-75.
1989: Beckmann M L; Nies A S; Gerber J G
Prostacyclin synthesis is increased during propranolol therapy for essential hypertension.
Advances in prostaglandin, thromboxane, and leukotriene research 1989;19():203-6.
1988: Beckmann M L; Gerber J G; Byyny R L; LoVerde M; Nies A S
Propranolol increases prostacyclin synthesis in patients with essential hypertension.
Hypertension 1988;12(6):582-8.
1988: Gerber J G
Is the parietal cell the major source of gastric mucosal prostaglandin E2?
Prostaglandins 1988;36(5):581-3.
1988: Zahniser N R; Parker D C; Bier-Laning C M; Miller J A; Gerber J G; Nies A S
Comparison between the effects of aging on antagonist and agonist interactions with beta-adrenergic receptors on human mononuclear and polymorphonuclear leukocyte membranes.
Journal of gerontology 1988;43(6):M151-7.
1988: Klein C; Hiatt W R; Gerber J G; Nies A S
Age does not alter human vascular and nonvascular beta 2-adrenergic responses to isoproterenol.
Clinical pharmacology and therapeutics 1988;44(5):573-8.
1988: Balazy M; Brass E P; Gerber J G; Nies A S
Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin.
Prostaglandins 1988;36(4):421-30.
1988: Chu K M; Gerber J G; Nies A S
Local vasodilator effect of platelet activating factor in the gastric, mesenteric and femoral arteries of the dog.
The Journal of pharmacology and experimental therapeutics 1988;246(3):996-1000.
1988: Gerber J G; Payne N A
Endogenous adenosine modulates gastric acid secretion to histamine in canine parietal cells.
The Journal of pharmacology and experimental therapeutics 1988;244(1):190-4.
1987: Gerber J G; Barnes J S
Histamine release in vivo by pentagastrin from the canine stomach.
The Journal of pharmacology and experimental therapeutics 1987;243(3):887-92.
1987: Payne N A; Gerber J G
Prostaglandin E2 and [14C]arachidonic acid release by carbachol in the isolated canine parietal cell.
The Journal of pharmacology and experimental therapeutics 1987;243(2):511-6.
1987: Schwertschlag U; Scherf H; Gerber J G; Mathias M; Nies A S
L-platelet activating factor induces changes on renal vascular resistance, vascular reactivity, and renin release in the isolated perfused rat kidney.
Circulation research 1987;60(4):534-9.
1987: Payne N A; Gerber J G
Stimulation of prostaglandin E2 release in canine gastric parietal cells.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17A():322-5.
1986: Scherf H; Nies A S; Schwertschlag U; Hughes M; Gerber J G
Hemodynamic effects of platelet activating factor in the dog kidney in vivo.
Hypertension 1986;8(9):737-41.
1986: Schwertschlag U; Gerber J G; Barnes J S; Nies A S
A dual effect of nonsteroidal anti-inflammatory drugs on renal water handling in humans.
The Journal of pharmacology and experimental therapeutics 1986;238(2):653-8.
1986: Schwertschlag U; Gerber J G; Barnes J S; Nies A S
Increased PGE2 excretion by dDAVP in humans depends on state of hydration.
The American journal of physiology 1986;250(6 Pt 2):F1008-12.
1986: Gerber J G; Hughes M; Payne N A
Somatostatin's ability to inhibit gastric acid is not prostaglandin-mediated in the dog.
European journal of pharmacology 1986;125(3):449-52.
1985: Roberts D G; Gerber J G; Barnes J S; Zerbe G O; Nies A S
Sulindac is not renal sparing in man.
Clinical pharmacology and therapeutics 1985;38(3):258-65.
1985: Gerber J G; Nies A S; Payne N A
Adenosine receptors on canine parietal cells modulate gastric acid secretion to histamine.
The Journal of pharmacology and experimental therapeutics 1985;233(3):623-7.
1984: Gerber J G; Payne N A; Fadul S; Nies A S
Cholinergic mechanism of acid secretion in the dog: an in vivo and in vitro comparison.
European journal of pharmacology 1984;106(2):373-80.
1984: Gerber J G; Fadul S; Payne N A; Nies A S
Adenosine: a modulator of gastric acid secretion in vivo.
The Journal of pharmacology and experimental therapeutics 1984;231(1):109-13.
1983: Johnston G D; Hiatt W R; Nies A S; Payne N A; Murphy R C; Gerber J G
Factors modifying the early nondiuretic vascular effects of furosemide in man. The possible role of renal prostaglandins.
Circulation research 1983;53(5):630-5.
1983: Nies A S; Gal J; Fadul S; Gerber J G
Indomethacin-furosemide interaction: the importance of renal blood flow.
The Journal of pharmacology and experimental therapeutics 1983;226(1):27-32.
1983: Perez-Reyes E; Payne N A; Gerber J G
Effect of somatostatin, secretin, and glucagon on secretagogue stimulated aminopyrine uptake in isolated canine parietal cells.
Agents and actions 1983;13(4):265-8.
1983: Nies A S; Fadul S; Gal J; Gerber J G
Indomethacin-furosemide interaction: the importance of renal blood flow.
Advances in prostaglandin, thromboxane, and leukotriene research 1983;11():529-33.
1982: Barnes J S; Dubocovich M L; Nies A S; Gerber J G
Lack of interaction between tricyclic antidepressants and clonidine at the alpha 2-adrenoceptor on human platelets.
Clinical pharmacology and therapeutics 1982;32(6):744-8.
1981: Gerber J G; Payne N A; Murphy R C; Nies A S
Prostacyclin produced by the pregnant uterus in the dog may act as a circulating vasodepressor substance.
The Journal of clinical investigation 1981;67(3):632-6.

Sign-in to see more